FIG. 8.

Activities of hBD3 and CAP18 against S. aureus wild type and mutants. The susceptibilities of S. aureus COL, femA, femD, fmtB, and fmtC mutants, and a vancomycin-resistant mutant (VM) to hBD3 (1 μg/ml) and CAP18 (0.5 μg/ml) were determined by the method described in Materials and Methods. Solid bars, hBD3; open bars, CAP18. The data are means ± standard deviations from three independent experiments.